• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估甲状腺结节细针抽吸物中的 RET/PTC:FISH 观点。

Assessing RET/PTC in thyroid nodule fine-needle aspirates: the FISH point of view.

机构信息

Department of Biomedical Sciences, M. Aresu Surgical Sciences, University of Cagliari, Cittadella Universitaria, Monserrato (Cagliari), Italy.

出版信息

Endocr Relat Cancer. 2013 Jun 27;20(4):527-36. doi: 10.1530/ERC-13-0157. Print 2013 Aug.

DOI:10.1530/ERC-13-0157
PMID:23722226
Abstract

RET/PTC rearrangement and BRAF(V600E) mutation are the two prevalent molecular alterations associated with papillary thyroid carcinoma (PTC), and their identification is increasingly being used as an adjunct to cytology in diagnosing PTC. However, there are caveats associated with the use of the molecular approach in fine-needle aspiration (FNA), particularly for RET/PTC, that should be taken into consideration. It has been claimed that a clonal or sporadic presence of this abnormality in follicular cells can distinguish between malignant and benign nodules. Nevertheless, the most commonly used PCR-based techniques lack the capacity to quantify the number of abnormal cells. Because fluorescence in situ hybridization (FISH) is the most sensitive method for detecting gene rearrangement in a single cell, we compared results from FISH and conventional RT-PCR obtained in FNA of a large cohort of consecutive patients with suspicious nodules and investigated the feasibility of setting a FISH-FNA threshold capable of distinguishing non-clonal from clonal molecular events. For this purpose, a home brew break-apart probe, able to recognize the physical breakage of RET, was designed. While a ≥3% FISH signal for broken RET was sufficient to distinguish nodules with abnormal follicular cells, only samples with a ≥6.8% break-apart FISH signal also exhibited positive RT-PCR results. On histological analysis, all nodules meeting the ≥6.8% threshold proved to be malignant. These data corroborate the power of FISH when compared with RT-PCR in quantifying the presence of RET/PTC in FNA and validate the RT-PCR efficiency in detecting clonal RET/PTC alterations.

摘要

RET/PTC 重排和 BRAF(V600E) 突变是与甲状腺乳头状癌(PTC)相关的两种常见分子改变,其鉴定越来越多地被用作细胞学诊断 PTC 的辅助手段。然而,在细针抽吸(FNA)中使用分子方法存在一些注意事项,特别是对于 RET/PTC,应该考虑这些注意事项。有人声称,滤泡细胞中这种异常的克隆或散在存在可以区分良恶性结节。然而,最常用的基于 PCR 的技术缺乏定量异常细胞数量的能力。由于荧光原位杂交(FISH)是检测单细胞基因重排的最敏感方法,我们比较了在可疑结节的大量连续患者的 FNA 中获得的 FISH 和常规 RT-PCR 的结果,并研究了设置 FISH-FNA 阈值以区分非克隆和克隆分子事件的可行性。为此,设计了一种能够识别 RET 物理断裂的自制断裂探针。虽然≥3%的 FISH 信号用于断裂 RET 足以区分具有异常滤泡细胞的结节,但只有≥6.8%的断裂 FISH 信号的样本也显示出阳性 RT-PCR 结果。在组织学分析中,所有符合≥6.8%阈值的结节均被证实为恶性。这些数据证实了 FISH 与 RT-PCR 相比在定量 FNA 中 RET/PTC 存在方面的强大功能,并验证了 RT-PCR 在检测克隆 RET/PTC 改变方面的效率。

相似文献

1
Assessing RET/PTC in thyroid nodule fine-needle aspirates: the FISH point of view.评估甲状腺结节细针抽吸物中的 RET/PTC:FISH 观点。
Endocr Relat Cancer. 2013 Jun 27;20(4):527-36. doi: 10.1530/ERC-13-0157. Print 2013 Aug.
2
Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application.RET/PTC 重排在甲状腺良恶性结节中的检出率及其临床应用。
Endocr J. 2011;58(1):31-8. doi: 10.1507/endocrj.k10e-260. Epub 2010 Dec 14.
3
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint.良性和恶性甲状腺疾病中的 RET/PTC 重排:临床观点。
Eur J Endocrinol. 2011 Oct;165(4):499-507. doi: 10.1530/EJE-11-0499. Epub 2011 Jul 12.
4
Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings.在术前诊断具有不确定细胞学结果的甲状腺结节中检测RET/PTC、TRK和BRAF突变。
Clin Endocrinol (Oxf). 2007 May;66(5):678-83. doi: 10.1111/j.1365-2265.2007.02800.x. Epub 2007 Mar 23.
5
Optimizing detection of RET and PPARg rearrangements in thyroid neoplastic cells using a home-brew tetracolor probe.使用自制四色探针优化甲状腺肿瘤细胞中 RET 和 PPARg 重排的检测。
Cancer Cytopathol. 2014 May;122(5):377-85. doi: 10.1002/cncy.21397. Epub 2014 Feb 7.
6
Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens.术前分子分析可部分克服细针穿刺活检(FNA)对甲状腺不确定结节的诊断局限性:BRAF和RAS野生型常规空气干燥FNA标本中RET/PTC1重排的评估
Int J Mol Sci. 2017 Apr 12;18(4):806. doi: 10.3390/ijms18040806.
7
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements.甲状腺乳头状癌中的分裂间期荧光原位杂交分析:迈向优化RET/PTC重排截断水平之路
Eur J Endocrinol. 2015 May;172(5):571-82. doi: 10.1530/EJE-14-0930. Epub 2015 Feb 19.
8
Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement.通过BRAF V600E突变和RET/PTC重排的细针穿刺分子分析诊断甲状腺乳头状癌
Thyroid. 2007 Nov;17(11):1109-15. doi: 10.1089/thy.2007.0008.
9
Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population.细针穿刺活检样本中分子检测的评估:中国人群的经验
Exp Mol Pathol. 2014 Oct;97(2):292-7. doi: 10.1016/j.yexmp.2014.08.005. Epub 2014 Aug 8.
10
Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".BRAF突变检测在细针穿刺活检样本中诊断为“疑似甲状腺乳头状癌”时的应用价值
Head Neck. 2015 Dec;37(12):1788-93. doi: 10.1002/hed.23829. Epub 2014 Sep 25.

引用本文的文献

1
Three-dimensional telomere profiles in papillary thyroid cancer variants: A pilot study.甲状腺乳头癌变异体中的三维端粒谱:一项初步研究。
Bosn J Basic Med Sci. 2022 Jun 1;22(3):481-487. doi: 10.17305/bjbms.2021.6639.
2
Ten tips for a text-mining-ready article: How to improve automated discoverability and interpretability.撰写便于文本挖掘文章的 10 个技巧:如何提高自动化可发现性和可解释性。
PLoS Biol. 2020 Jun 1;18(6):e3000716. doi: 10.1371/journal.pbio.3000716. eCollection 2020 Jun.
3
Thyrospheres from B-CPAP Cell Line with and Promoter Mutations have Different Functional and Molecular Features than Parental Cells.
具有启动子突变的B-CPAP细胞系来源的甲状腺球与亲代细胞相比具有不同的功能和分子特征。
J Cancer. 2017 Jun 3;8(9):1629-1639. doi: 10.7150/jca.18855. eCollection 2017.
4
Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma.甲状腺乳头状癌中HER2扩增与端粒缩短的基因异质性
Int J Mol Sci. 2016 Oct 21;17(10):1759. doi: 10.3390/ijms17101759.
5
Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment?临床淋巴结阴性的乳头状甲状腺癌患者行甲状腺全切术时不进行预防性中央区颈淋巴结清扫:这是一种充分的治疗方法吗?
World J Surg Oncol. 2014 May 20;12:152. doi: 10.1186/1477-7819-12-152.
6
Follicular nodules (Thy3) of the thyroid: is total thyroidectomy the best option?甲状腺滤泡性结节(Thy3):甲状腺全切除术是最佳选择吗?
BMC Surg. 2014 Mar 6;14:12. doi: 10.1186/1471-2482-14-12.
7
Optimizing detection of RET and PPARg rearrangements in thyroid neoplastic cells using a home-brew tetracolor probe.使用自制四色探针优化甲状腺肿瘤细胞中 RET 和 PPARg 重排的检测。
Cancer Cytopathol. 2014 May;122(5):377-85. doi: 10.1002/cncy.21397. Epub 2014 Feb 7.
8
Differentiated thyroid cancer: indications and extent of central neck dissection--our experience.分化型甲状腺癌:中央区颈淋巴结清扫的指征与范围——我们的经验
Int J Surg Oncol. 2013;2013:625193. doi: 10.1155/2013/625193. Epub 2013 Sep 26.
9
An alternative approach in endocrine pathology research: MALDI-IMS in papillary thyroid carcinoma.内分泌病理学研究中的一种替代方法:基质辅助激光解吸电离成像质谱技术在甲状腺乳头状癌中的应用
Endocr Pathol. 2013 Dec;24(4):250-3. doi: 10.1007/s12022-013-9273-8.